Cancer Screening in Older Adults

Ashley H. Snyder; Allison Magnuson; Amy M. Westcott

doi:10.1016/j.mcna.2016.04.016

Cancer Screening in Older Adults

Ashley H. Snyder, Allison Magnuson, Amy M. Westcott

Research output: Contribution to journal › Review article

2 Scopus citations

Abstract

When screening for cancer in older adults, it is important to consider the risks of screening, how long it takes to benefit from screening, and the patient's comorbidities and life expectancy. Delivering high-value care requires the consideration of evidence-based screening guidelines and careful selection of patients. This article considers the impact of cancer. It explores perspectives on the costs of common cancer screening tests, illustrates how using life expectancy can help clinicians determine who will benefit most from screening, and provides tools to help clinicians discuss with their older patients when it may be appropriate to stop screening for cancer.

Original language	English (US)
Pages (from-to)	1101-1110
Number of pages	10
Journal	Medical Clinics of North America
Volume	100
Issue number	5
DOIs	https://doi.org/10.1016/j.mcna.2016.04.016
Publication status	Published - Jan 1 2016

Fingerprint

All Science Journal Classification (ASJC) codes

Medicine(all)

Cite this

Snyder, A. H., Magnuson, A., & Westcott, A. M. (2016). Cancer Screening in Older Adults. Medical Clinics of North America, 100(5), 1101-1110. https://doi.org/10.1016/j.mcna.2016.04.016

@article{b0966553df8e45b2971808fa290e5890,

title = "Cancer Screening in Older Adults",

abstract = "When screening for cancer in older adults, it is important to consider the risks of screening, how long it takes to benefit from screening, and the patient's comorbidities and life expectancy. Delivering high-value care requires the consideration of evidence-based screening guidelines and careful selection of patients. This article considers the impact of cancer. It explores perspectives on the costs of common cancer screening tests, illustrates how using life expectancy can help clinicians determine who will benefit most from screening, and provides tools to help clinicians discuss with their older patients when it may be appropriate to stop screening for cancer.",

author = "Snyder, {Ashley H.} and Allison Magnuson and Westcott, {Amy M.}",

year = "2016",

month = "1",

day = "1",

doi = "10.1016/j.mcna.2016.04.016",

language = "English (US)",

volume = "100",

pages = "1101--1110",

journal = "Medical Clinics of North America",

issn = "0025-7125",

publisher = "W.B. Saunders Ltd",

number = "5",

}

TY - JOUR

T1 - Cancer Screening in Older Adults

AU - Snyder, Ashley H.

AU - Magnuson, Allison

AU - Westcott, Amy M.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - When screening for cancer in older adults, it is important to consider the risks of screening, how long it takes to benefit from screening, and the patient's comorbidities and life expectancy. Delivering high-value care requires the consideration of evidence-based screening guidelines and careful selection of patients. This article considers the impact of cancer. It explores perspectives on the costs of common cancer screening tests, illustrates how using life expectancy can help clinicians determine who will benefit most from screening, and provides tools to help clinicians discuss with their older patients when it may be appropriate to stop screening for cancer.

AB - When screening for cancer in older adults, it is important to consider the risks of screening, how long it takes to benefit from screening, and the patient's comorbidities and life expectancy. Delivering high-value care requires the consideration of evidence-based screening guidelines and careful selection of patients. This article considers the impact of cancer. It explores perspectives on the costs of common cancer screening tests, illustrates how using life expectancy can help clinicians determine who will benefit most from screening, and provides tools to help clinicians discuss with their older patients when it may be appropriate to stop screening for cancer.

UR - http://www.scopus.com/inward/record.url?scp=84998785488&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84998785488&partnerID=8YFLogxK

U2 - 10.1016/j.mcna.2016.04.016

DO - 10.1016/j.mcna.2016.04.016

M3 - Review article

C2 - 27542429

AN - SCOPUS:84998785488

VL - 100

SP - 1101

EP - 1110

JO - Medical Clinics of North America

JF - Medical Clinics of North America

SN - 0025-7125

IS - 5

ER -

Access to Document

10.1016/j.mcna.2016.04.016